{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:46:27Z","timestamp":1759340787700},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijsu.2017.03.077","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T19:56:18Z","timestamp":1490903778000},"page":"143-149","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study"],"prefix":"10.1097","volume":"41","author":[{"given":"Giacomo","family":"Pata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bartoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Solari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Anastasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"26","key":"10.1016\/j.ijsu.2017.03.077_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2012.177","article-title":"Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP long course","volume":"1","author":"Swerdlow","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib2","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib3","first-page":"194","article-title":"Splenic marginalzone lymphoma: current knowledge and future directions","volume":"26","author":"Thieblemont","year":"2012","journal-title":"Oncol. Willist. Park"},{"key":"10.1016\/j.ijsu.2017.03.077_bib4","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Integruppo italiano linfomi. Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijsu.2017.03.077_bib5","series-title":"World Health Organization. Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"185","article-title":"Splenic B-cell marginal zone lymphoma","author":"Isaacson","year":"2008"},{"key":"10.1016\/j.ijsu.2017.03.077_bib6","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ijsu.2017.03.077_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3816\/CLM.2002.n.010","article-title":"Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients","volume":"3","author":"Thieblemont","year":"2002","journal-title":"Clin. Lymphoma"},{"key":"10.1016\/j.ijsu.2017.03.077_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-007-0026-0","article-title":"Splenic marginal zone lymphoma with and without villous lymphocytes","volume":"8","author":"Matutes","year":"2007","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00277-013-1900-4","article-title":"Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma","volume":"93","author":"Olszewski","year":"2014","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib10","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.ijsu.2017.03.077_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijsu.2017.03.077_bib13","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1182\/blood-2002-07-2216","article-title":"Splenic marginal zone lymphoma","volume":"101","author":"Franco","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ijsu.2017.03.077_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.blre.2004.03.002","article-title":"Splenic marginal zone lymphoma","volume":"19","author":"Oscier","year":"2005","journal-title":"Blood Rev."},{"key":"10.1016\/j.ijsu.2017.03.077_bib15","first-page":"194","article-title":"Splenic marginal zone lymphoma: current knowledge and future directions","volume":"26","author":"Thieblemont","year":"2012","journal-title":"Oncol. Willist. Park"},{"key":"10.1016\/j.ijsu.2017.03.077_bib16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cncr.11893","article-title":"Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles","volume":"100","author":"Arcaini","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2017.03.077_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1470-2045(03)00981-1","article-title":"Splenic marginal-zone lymphoma: a distinct clinical and pathological entity","volume":"4","author":"Thieblemont","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V100.5.1648.h81702001648_1648_1654","article-title":"Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients","volume":"100","author":"Chac\u00f3n","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ijsu.2017.03.077_bib19","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.1991.tb04417.x","article-title":"Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases","volume":"78","author":"Mulligan","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/bjh.13320","article-title":"Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia","volume":"169","author":"Xing","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3109\/10428194.2013.861067","article-title":"Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment","volume":"55","author":"Lenglet","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ijsu.2017.03.077_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3109\/10428194.2013.845884","article-title":"Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?","volume":"55","author":"Kalpadakis","year":"2014","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ijsu.2017.03.077_bib23","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1182\/blood.V95.6.1950","article-title":"Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients","volume":"95","author":"Berger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ijsu.2017.03.077_bib24","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ijsu.2017.03.077_bib25","first-page":"856","article-title":"Rituximab monotherapy for splenic marginal zone lymphoma","volume":"90","author":"Bennett","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.ijsu.2017.03.077_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cncr.21931","article-title":"Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone","volume":"107","author":"Tsimberidou","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2017.03.077_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/hon.820","article-title":"Rituximab monotherapy is highly effective in splenic marginal zone lymphoma","volume":"25","author":"Kalpadakis","year":"2007","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.seminhematol.2010.01.004","article-title":"Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab","volume":"47","author":"Bennett","year":"2010","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3816\/CLM.2006.n.033","article-title":"Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia","volume":"6","author":"Fabbri","year":"2006","journal-title":"Clin. Lymphoma Myeloma"},{"key":"10.1016\/j.ijsu.2017.03.077_bib30","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/1042819031000123555","article-title":"Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase","volume":"44","author":"Paydas","year":"2003","journal-title":"Leuk. Lymphoma"},{"issue":"3","key":"10.1016\/j.ijsu.2017.03.077_bib31","first-page":"1","article-title":"Splenectomy in splenic marginal zone lymphoma: a single center experience. 45\u00b0 congress of the Italian Society of Hematology Florence, Italy, October 4\u20137, 2015","volume":"100","author":"Pagani","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.ijsu.2017.03.077_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/17474086.2013.845522","article-title":"Splenic marginal zone lymphoma: disease features and management","volume":"6","author":"Matutes","year":"2013","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib33","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.3748\/wjg.v19.i24.3854","article-title":"Laparoscopic splenectomy for treatment of splenic marginal zone lymphoma","volume":"19","author":"Wu","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijsu.2017.03.077_bib34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajh.20018","article-title":"Thromboembolic complications after splenectomy for hematologic diseases","volume":"76","author":"Mohren","year":"2004","journal-title":"Am. J. Hematol."}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919117303011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919117303011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:04:54Z","timestamp":1677063894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919117303011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":34,"alternative-id":["S1743919117303011"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2017.03.077","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Still a role for surgery as first-line therapy of splenic marginal zone lymphoma? Results of a prospective observational study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2017.03.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}